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Population-based Screening Study
Högberg D., Kragsterman B., Björck M., Tjärnström J., Wanhainen A. Eur
J Vasc Endovasc Surg 2014;48:5-10.
Objective: There are limited contemporary epidemiological data on
the prevalence of carotid atherosclerosis in the general population. The
aim was to determine the prevalence of and risk factors associated with ca-
rotid artery atherosclerosis among 65-year-old men.
Methods: This was a population-based screening study. All 65-year-
old men in the County of Uppsala, Sweden, who attended screening for
abdominal aortic aneurysm (AAA) 2007e2009, were invited for duplex
scanning of the carotid arteries.
Results: Of 4801 men invited, 4657 (97%) accepted. Carotid plaques
(>2  6 mm) were observed in 1169 (25%) men, 94 (2.0%) had carotid ste-
noses (50e99%), and 15 (0.3%) had occluded carotid arteries. In a multivar-
iate logistic regression model, smoking (OR 1.7, 95% CI 1.5e1.9),
hypertension (1.5, 95% CI 1.3e1.7), diabetes mellitus (1.2, 95% CI
1.0e1.5), and coronary artery disease (1.5, 95% CI 1.3e1.8) were associ-
ated with prevalence of carotid atherosclerosis (plaque and/or stenosis).
The use of antiplatelet agents and statins in participants with a carotid pla-
que was 20% and 29%, respectively. The corresponding ﬁgures in partici-
pants with a stenosis were 42% and 41%.
Conclusions: This study offers contemporary data on the prevalence
of carotid atherosclerosis in a population-based cohort of 65-year-old
men. Most of those at risk had no other clinical manifestation of atheroscle-
rosis, and therefore had no secondary prevention.
Treatment Decisions for Descending Thoracic Aneurysm: Preferences
for Thoracic Endovascular Aneurysm Repair or Surveillance in a
Discrete Choice Experiment
Rudarakanchana N., Reeves B.C., Bicknell C.D., Heatley F.M.,
Cheshire N.J., Powell J.T. Eur J Vasc Endovasc Surg 2014;48:13-22.
Objective: To investigate and rank factors that inﬂuence endovascular
treatment decisions by specialists for patients with descending thoracic
aortic aneurysm (dTAA).
Methods: Specialists completed a diagrammatic survey describing un-
certainty about the beneﬁt of thoracic endovascular aneurysm repair
(TEVAR) for dTAA with respect to age, sex, and aneurysm diameter. Sub-
sequently, a detailed discrete choice experiment was designed. Specialists
were recruited and asked to indicate treatment their preference (TEVAR
or surveillance) in 25 hypothetical cases of dTAA, with variable patient at-
tributes: age, sex, American Society of Anesthesiologists (ASA) grade, aneu-
rysm diameter, adequate landing zone distal to left subclavian artery (LSA),
and length of aortic coverage. Data were analysed using multiple logistic
regression.
Results: The diagrammatic survey, based on 50 respondents, showed
that uncertainty about the beneﬁts of TEVAR was greatest for patients aged
80e85 years (up to 47% of respondents were “unsure”) and that uncer-
tainty increased with increasing aneurysm diameter (for an 80-year-old
man, 7% were unsure at 5.5 cm and 33% were unsure at 7.0 cm). Sev-
enty-one specialists (mainly from Europe and North America, 86% vascular
surgeons and 98% working in units offering TEVAR) completed the discrete
choice experiment. Preference for TEVAR increased greatly with enlarging
diameter: adjusted odds ratios (OR) >5.5e6.0 cm = 15.8 (95% conﬁdence
interval [CI] 9.83e25.40); >6.0e6.5 cm = 393.0 (95% CI
202.00e766.00); >6.5e7.0 cm = 1829.0 (95% CI 400.00e4,181.00).
TEVAR was less likely to be preferred in patients older than 75 years
(>75e80 years OR 0.32, 95% CI 0.21e0.49; >80e85 years = 0.18, 95%
CI 0.11e0.28); in women (OR 0.52, 95% CI 0.37e0.74); in patients clas-
siﬁed as ASA grade 4 (OR 0.44, 95% CI 0.36e0.57); and in patients with
aorta coverage >25 cm (OR 0.48, 95% CI 0.32e0.74). The proximal land-
ing zone did not inﬂuence preference.
Conclusion: Specialists' preferences for endovascular repair of degen-
erative dTAA vary widely, and demonstrate clinical uncertainty, especially in
octogenarians, and a reluctance to offer TEVAR to women. Aneurysmdiameter dominates treatment preferences, but patient ﬁtness and length
of aortic coverage (>25 cm) also were inﬂuential, although the landing
zone distal to LSA was not.
Spontaneous Delayed Sealing in Selected Patients with a Primary
Type-Ia Endoleak After Endovascular Aneurysm Repair
Bastos Gonçalves F., Verhagen H.J.M., Vasanthananthan K.,
Zandvoort H.J.A., Moll F.L., van Herwaarden J.A. Eur J Vasc Endovasc
Surg 2014;48:53-9.
Objective: Direct additional therapy is advised for type-Ia endoleaks
detected on completion angiography after endovascular aneurysm repair
(EVAR). Additional intraoperative endovascular procedures are, however,
often challenging or not possible, and direct open conversion is unattractive.
The results of a selective, conservative strategy for patients with primary
type-Ia endoleak has been analysed.
Methods: This was a retrospective, single-centre study (UMC,
Utrecht, NL). From 2004 to 2008, all patients with a primary type-Ia endo-
leak and suitable anatomy for EVAR, stentgraft oversizing $15%, and
optimal deployment were included. Complications during follow-up were
studied and all sequential CTA scans were reviewed. These were compared
with the remaining patients, treated during the same period.
Results: Fifteen patients were included (14 male, median age 77,
range 67e85) with a median aneurysm diameter of 60 mm (48e80),
an aneurysm neck diameter of 26 mm (21e32), a neck length of 29
mm (11e39), and infrarenal angulation of 49 (31e90). One patient suf-
fered rupture 2 days after EVAR e leading to the only AAA-related death.
Eight of the 15 type-Ia endoleaks disappeared spontaneously on the ﬁrst
postoperative CTA, obtained within 1 week of EVAR. On the second
postoperative CTA, obtained a median of 5 months (1e12) after
EVAR, all remaining endoleaks had sealed. One recurrence occurred at
4.85 years. During a median follow-up of 3.3 years, there were ﬁve sec-
ondary interventions. Compared with controls, there were more second-
ary (or recurrent) type-1a endoleaks (13% vs. 4%), endograft migrations
(13% vs. 3%), sac growths (33% vs. 16%), and secondary interventions
(33% vs. 23%). None of these differences however, were statistically
signiﬁcant.
Conclusions: All but one of the primary type-Ia endoleaks sealed
spontaneously. Until sealing, the risk of rupture persisted, but subsequently
only one recurrence of type-Ia endoleak was seen. In selected patients, a
conservative approach for primary type-Ia endoleaks may be justiﬁed.
Healthcare Quality Indicators of Peripheral Artery Disease Based on
Systematic Reviews
Bellmunt S., Roqué M., Osorio D., Pardo H., Escudero J.-R., Bonﬁll X. Eur
J Vasc Endovasc Surg 2014;48:60-9.
Objectives: Peripheral artery disease (PAD) is a major health problem
whose clinical management includes multiple options regarding risk factor
control, diagnosis, and medical and surgical treatment. The aim was to
generate indicators based on systematic reviews to evaluate the quality of
healthcare provided in PAD.
Methods: Electronic searches were run for systematic reviews in The
Cochrane Library (Issue 6, 2011), MEDLINE, EMBASE, and other data-
bases (up to June 2011). Conclusive systematic reviews of high methodo-
logical quality were selected to formulate clinical recommendations.
Indicators were derived from clinical recommendations with moderate to
very high strength of evidence as assessed by the GRADE system.
Results: From 1,804 reviews initially identiﬁed, 29 conclusive and
high-quality systematic reviews were selected and nine clinical recommenda-
tions were formulated with a moderate to very high strength of recommen-
dation. Six indicators were ﬁnally generated: four on pharmacological
interventions, antiplatelet agents, naftidrofuryl, cilostazol, and statins; and
two lifestyle interventions, exercise and tobacco cessation. No indicators
were derived for diagnostic tests or surgical techniques. Most indicators tar-
geted patients with intermittent claudication.267
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appropriateness of healthcare provided in PAD. The development of evi-
dence-based indicators in PAD is limited by the lack of methodological
quality of the research in this disease, the inconclusiveness of the evidence
on diagnostic and surgical techniques, and the dynamic nature of the
vascular diseases ﬁeld.
Systematic Review and Meta-analysis of Direct Versus Indirect
Angiosomal Revascularisation of Infrapopliteal Arteries
Bosanquet D.C., Glasbey J.C.D., Williams I.M., Twine C.P. Eur J Vasc
Endovasc Surg 2014;48:88-97.
Objective: The aim of this systematic review was to evaluate out-
comes of direct revascularisation (DR) versus indirect revascularisation
(IR) of infrapopliteal arteries to the affected angiosome for critical limb
ischaemia. Both open and endovascular techniques were included.
Methods: A systematic review of key electronic journal databases was
undertaken from inception to 22 March 2014. Studies comparing DR
versus IR in patients with localised tissue loss were included. Meta-analysis
was performed for wound healing, limb salvage, mortality, and re-interven-
tion rates, with numerous sensitivity analyses. Quality of evidence was
assessed using the Grading of Recommendations Assessment, Development
and Evaluation (GRADE) system.
Results: Fifteen cohort studies reporting on 1,868 individual limbs
were included (endovascular revascularisation, 1,284 limbs; surgical revascu-
larisation, 508 limbs; both methods, 76 limbs). GRADE quality of evidence
was low or very low for all outcomes. DR resulted in improved wound heal-
ing rates compared with IR (odds ratio [OR] 0.40, 95% conﬁdence interval
[CI] 0.29e0.54) and improved limb salvage rates (OR 0.24, 95% CI
0.13e0.45), although this latter effect was lost on high-quality study sensi-
tivity analysis. Wound healing and limb salvage was improved for both open
and endovascular intervention. There was no effect on mortality (OR 0.77,
95% CI 0.50e1.19) or reintervention rates (OR: 0.44, 95% CI 0.10e1.88).Conclusion: DR of the tibial vessels appears to result in improved
wound healing and limb salvage rates compared with IR, with no effect
on mortality or reintervention rates. However, the quality of evidence on
which these conclusions are based on is low.
Role of Sinus in Prosthetic Venous Valve
Tien W.-H., Chen H.Y., Berwick Z.C., Krieger J., Chambers S., Dabiri D.,
Kassab G.S. Eur J Vasc Endovasc Surg 2014;48:98-104.
Background: The majority of bioprosthetic venous valves do not have
a sinus pocket and, in practice, they are often placed in non-sinus segments
of the veins. The aim of this study is to investigate the effect of the sinus
pocket on the ﬂow dynamics in a prosthetic valve.
Methods: A bench top in vitro experiment was set up at physiological
ﬂow conditions to simulate the ﬂow inside a venous system. Bicuspid bio-
prosthetic valves with different leaﬂet lengths (5 and 10 mm) were tested
in tubes with and without a sinus pocket and the ﬂows around the valve
were visualized by particle image velocimetry (PIV). Velocity data measure-
ments were made and the vorticity was calculated in the with- and without-
sinus set-ups.
Results: PIV measurements showed that vortex structure was
maintained by the sinus. For the 10-mm leaﬂet length design with sinus,
the jet width at the exit of the valve was 59% of that without sinus. For
the 5-mm design with sinus, the jet width was 73% of the valve without
sinus. Flow from the sinus region was entrained into the main jet
observed near the exit of the sinus and altered the ﬂow at the near wall
region.
Conclusions: The sinus pocket alters the ﬂow around the valve and
functions as ﬂow regulator to smooth the ﬂow pattern around the valve.
The vortical structure inside the sinus is maintained at the valve leaﬂet tip
during the valve cycle. For the prosthetic valve designated to be placed
without a sinus, a shorter leaﬂet length is preferable and performs more
closely to the valve with sinus.
